Grindr's Majority Shareholders Propose $18/Share Buyout to Take Company Private
Grindr's majority shareholders propose $18 per share buyout to take the dating app private. 51% premium offer targets Q1 2026 closing.
NOTRELOAD AI
JPMorgan Boosts Coinbase Rating, Eyes $34B Base Token Opportunity
JPMorgan upgrades Coinbase to overweight with $404 price target, citing potential Base token worth up to $34B and new revenue streams from USDC yields.
ImageneBio Stock: Why Analysts See 150% Upside Despite Competitor Setbacks
Leerink rates ImageneBio stock Outperform with $30 target, calling it "undervalued."
Lilly Acquires Adverum for One-Time Eye Disease Gene Therapy
Eli Lilly announces acquisition of Adverum Biotechnologies for up to $12.47 per share to advance Ixo-vec, a promising one-time gene therapy for age-related macular degeneration.
Kura Oncology Shares Jump 6% After $30M Milestone Payment for Cancer Drug Trial
Kura Oncology stock rises 6% in premarket trading after receiving $30 million milestone payment from Kyowa Kirin for Phase 3 cancer drug trial advancement.
P&G Beats Expectations as Beauty Products Drive Growth Despite Price Hikes
Procter & Gamble reports stronger-than-expected Q1 results with 2% organic growth, driven by beauty and grooming sales as consumers accept premium pricing strategy.